These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34453927)

  • 21. Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach.
    Ferrati S; Wu T; Fuentes O; Brunaugh AD; Kanapuram SR; Smyth HDC
    AAPS PharmSciTech; 2018 Oct; 19(7):2755-2766. PubMed ID: 29488193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
    Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
    Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
    Weers JG; Miller DP; Tarara TE
    AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME; Lamprecht A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Gomez M; McCollum J; Wang H; Bachchhav S; Tetreau I; Gerhardt A; Press C; Kramer RM; Fox CB; Vehring R
    Vaccine; 2021 Aug; 39(35):5025-5036. PubMed ID: 34256969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.
    Costantino HR; Firouzabadian L; Hogeland K; Wu C; Beganski C; Carrasquillo KG; Córdova M; Griebenow K; Zale SE; Tracy MA
    Pharm Res; 2000 Nov; 17(11):1374-83. PubMed ID: 11205730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect.
    Barcelo-Chong CM; Filipe V; Nakach M; Inês Ré M
    Int J Pharm; 2024 Apr; 655():124014. PubMed ID: 38513817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
    Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
    Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrostatic spray drying for monoclonal antibody formulation.
    Mutukuri TT; Maa YF; Gikanga B; Sakhnovsky R; Zhou QT
    Int J Pharm; 2021 Sep; 607():120942. PubMed ID: 34324986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of favipiravir dry powders for intranasal delivery: An integrated cocrystal and particle engineering approach via spray freeze drying.
    Wong SN; Li S; Low KH; Chan HW; Zhang X; Chow S; Hui B; Chow PCY; Chow SF
    Int J Pharm; 2024 Mar; 653():123896. PubMed ID: 38346602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
    Kozáková J; Altay A; Ždímal V; Mašková L; Sonvico F; Quarta E; Rossi A; Buttini F; Colombo G
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1664-1673. PubMed ID: 31389270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process].
    Ito T
    Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
    Sonner C; Maa YF; Lee G
    J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
    Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
    Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
    Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.